Table 2.
Dose of Immunogen (µg per Balb/c Mice) |
mAb | IC50 for AFM1 (ng mL−1) | Cross-Reactivity (%) | ||||
---|---|---|---|---|---|---|---|
AFM1 | AFB1 | AFB2 | AFG1 | AFG2 | |||
16 | 2C9 | 0.067 | 100 | <1 | <1 | <1 | <1 |
16 | 3C4 | 0.043 | 100 | <1 | <1 | <1 | <1 |
16 | 1D7 | 0.058 | 100 | <1 | <1 | <1 | <1 |
65 | LM43 | 0.014 | 100 | <1 | <1 | <1 | <1 |
65 | LM3 | 0.029 | 100 | 1 | <1 | <1 | <1 |
65 | LM10 | 0.034 | 100 | 1 | <1 | <1 | <1 |
65 | LM14 | 0.017 | 100 | 1 | <1 | <1 | <1 |
65 | LM47 | 0.020 | 100 | 1 | <1 | <1 | <1 |
65 | LM15 | 0.006 | 100 | 1 | <1 | <1 | <1 |
65 | LM20 | 0.011 | 100 | 2 | <1 | <1 | <1 |
65 | LM39 | 0.069 | 100 | 2 | <1 | <1 | <1 |
65 | LM37 | 0.017 | 100 | 3 | <1 | <1 | <1 |
65 | LM54 | 0.029 | 100 | 3 | <1 | <1 | <1 |
65 | LM16 | 0.030 | 100 | 3 | <1 | 1 | <1 |
65 | LM40 | 0.029 | 100 | 5 | <1 | 2 | <1 |
65 | LM7 | 0.052 | 100 | 5 | <1 | 2 | <1 |
65 | LM4 | 0.014 | 100 | 6 | <1 | 3 | <1 |
65 | LM17 | 0.069 | 100 | 14 | 6 | <1 | 2 |
65 | LM13 | 0.011 | 100 | 20 | 3 | <1 | 2 |
65 | LM41 | 0.015 | 100 | 11 | 10 | 1 | 11 |
65 | LM9 | 0.014 | 100 | 11 | 8 | 1 | 3 |
65 | LM21 | 0.011 | 100 | 19 | 18 | 2 | 22 |
65 | LM30 | 0.023 | 100 | 33 | 20 | 9 | 10 |
65 | LM38 | 0.014 | 100 | 40 | 22 | 4 | 16 |
65 | LM46 | 0.011 | 100 | 40 | 22 | 25 | 18 |
65 | LM48 | 0.012 | 100 | 74 | 57 | 21 | 65 |
65 | LM28 | 0.012 | 100 | 75 | 47 | 18 | 102 |
65 | LM44 | 0.019 | 100 | 78 | 15 | 43 | 9 |
65 | LM11 | 0.019 | 100 | 86 | 18 | 14 | 15 |
65 | LM49 | 0.019 | 100 | 92 | 30 | 66 | 74 |
65 | LM33 | 0.013 | 100 | 101 | 97 | 13 | 11 |
65 | LM50 | 0.035 | 100 | 112 | 39 | 31 | 32 |
65 | LM32 | 0.046 | 100 | 114 | 67 | 60 | 110 |
65 | LM51 | 0.023 | 100 | 175 | 29 | 59 | 39 |